Frazier Financial Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-226
Closed -$2.84K 895
2024
Q3
$2.84K Buy
226
+19
+9% +$207 ﹤0.01% 650
2024
Q2
$1.76K Sell
207
-364
-64% -$3.24K ﹤0.01% 808
2024
Q1
$6.01K Buy
571
+464
+434% +$5.15K ﹤0.01% 547
2023
Q4
$1.11K Buy
+107
New +$853 ﹤0.01% 744

Other funds holding ZYME

Frazier Financial Advisors's ZYME Position: Q4 2024 in Review

Frazier Financial Advisors sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 226 shares — an estimated $2.84K sold.

Frazier Financial Advisors first reported a position in ZYME in Q4 2023 and held it in 4 quarters. The position peaked at $6.01K in Q1 2024. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.

  • Frazier Financial Advisors reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
  • Frazier Financial Advisors sold 226 Zymeworks shares in Q4 2024, an estimated $2.84K.
  • Frazier Financial Advisors first reported a position in Zymeworks in Q4 2023 and held it in 4 quarters.
  • Frazier Financial Advisors's Zymeworks position peaked at $6.01K in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.

Based on Frazier Financial Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.